Aronex, Boehringer Mannheim GmbH deal

Boehringer Mannheim received exclusive worldwide rights to ARNX's AR 209

Read the full 105 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE